DealsArchiMed completes take-private deal of Natus for $1.1bnAs a result of the closing, Natus will no longer trade on the NASDAQ.ByIris Dorbian21 July 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs